Reta 50mg
Research-grade peptide

Reta 50mg
A triple agonist peptide targeting the GLP-1, GIP and glucagon receptors, investigated in metabolic research. Supplied strictly for laboratory research use only — not for human or veterinary use.
C221H342N46O68
50mg
Lyophilised powder
Product Description
Reta 50mg is supplied as a research-grade lyophilised peptide with the molecular formula C221H342N46O68, containing 50mg of peptide per vial, intended strictly for in-vitro laboratory research. Certificates of Analysis and product documentation are available on request.
RTTA 50mg supplied as lyophilised powder for laboratory research use only. Certificates of Analysis and product documentation are available on request.
IMPORTANT: This product is for research purposes only. Not intended for human or veterinary use, consumption or administration.
RESEARCH USE ONLY
Materials are supplied exclusively for legitimate laboratory and scientific research and are not intended for human or veterinary use, diagnosis, treatment or therapeutic application.





